TT

Thomas Tom Duthy

Oncosil Medical Limited | Non-Executive Director, Non-Executive Chairman
Dr Duthy brings more than 21 years of experience across financial markets, corporate development, and board-level roles in the healthcare and life sciences sectors. He was previously Head of Corporate Development and Investor Relations at Sirtex Medical (ASX:SRX). Dr Duthy is the Founder and Director of Nemean Group, a corporate advisory firm serving healthcare and technology companies, and has been involved in M&A transactions. He currently advises Mayne Pharma (ASX:MYX) and serves as a Non-Executive Director of Invex Therapeutics (ASX:IXC).

Company and Roles

Company
Title
Tenure
Since
OSL
OSL
Oncosil Medical Limited
  • Non-Executive Director
  • Non-Executive Chairman
10mthJul 2025

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OSL
OSL
Oncosil Medical Limited
17/03/26091,604223,348N/A
IXC
IXC
30/06/25N/A285,661N/AN/A
ALA
ALA
26/11/24N/A4,747,4447,460,736N/A
NTI
NTI
30/06/24N/A340,00020,000,000N/A
PAA
PAA
01/02/24N/A250,000166,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
OSL
Oncosil Medical Limited
17/03/26
Issued
50,537$0.550$27,795Placement
OSL
OSL
Oncosil Medical Limited
17/03/26
Issued
50,537$0.680$34,365Placement
OSL
OSL
Oncosil Medical Limited
01/12/25
Issued
172,811$1.112$192,252Director remuneration
OSL
OSL
Oncosil Medical Limited
01/12/25
Issued
41,067$1.112$45,687Director remuneration
ALA
ALA
26/11/24
Issued
620,000$0.185$114,700Director remuneration